Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fairchild

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|March 20, 2008
Preclinical efficacy spectrum and pharmacokinetics of ixabepiloneFrancis Y F Lee, Richard Smykla, Kathy Johnston, et al.
Cancer Research|March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)B H Long, J M Carboni, A J Wasserman, et al.
Organic Letters|November 5, 2005
Antineoplastic diterpene-benzoate macrolides from the Fijian red alga Callophycus serratusJulia Kubanek, Anne C Prusak, Terry W Snell, et al.
Transplantation Proceedings|June 19, 2001
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label studyD R Snydman, M E Falagas, R Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacyF Y Lee, R Borzilleri, C R Fairchild, et al.
Organic Letters|August 17, 2001
Synthesis and biological activity of novel epothilone aziridinesA Regueiro-Ren, R M Borzilleri, X Zheng, et al.
British Journal of Cancer|October 21, 2004
Fhit-deficient normal and cancer cells are mitomycin C and UVC resistantM Ottey, S-Y Han, T Druck, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2005
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterizationWilliam C Rose, Punit H Marathe, Graham R Jang, et al.
Transplantation|June 27, 2000
A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplantsS M Flechner, D A Goldfarb, R Fairchild, et al.
The Journal of Organic Chemistry|March 11, 2009
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratusAmy L Lane, E Paige Stout, An-Shen Lin, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|March 20, 2008
Preclinical efficacy spectrum and pharmacokinetics of ixabepiloneFrancis Y F Lee, Richard Smykla, Kathy Johnston, et al.
Cancer Research|March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)B H Long, J M Carboni, A J Wasserman, et al.
Organic Letters|November 5, 2005
Antineoplastic diterpene-benzoate macrolides from the Fijian red alga Callophycus serratusJulia Kubanek, Anne C Prusak, Terry W Snell, et al.
Transplantation Proceedings|June 19, 2001
Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label studyD R Snydman, M E Falagas, R Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacyF Y Lee, R Borzilleri, C R Fairchild, et al.
Organic Letters|August 17, 2001
Synthesis and biological activity of novel epothilone aziridinesA Regueiro-Ren, R M Borzilleri, X Zheng, et al.
British Journal of Cancer|October 21, 2004
Fhit-deficient normal and cancer cells are mitomycin C and UVC resistantM Ottey, S-Y Han, T Druck, et al.
Cancer Chemotherapy and Pharmacology|October 18, 2005
Novel fluoro-substituted camptothecins: in vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterizationWilliam C Rose, Punit H Marathe, Graham R Jang, et al.
Transplantation|June 27, 2000
A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplantsS M Flechner, D A Goldfarb, R Fairchild, et al.
The Journal of Organic Chemistry|March 11, 2009
Antimalarial bromophycolides J-Q from the Fijian red alga Callophycus serratusAmy L Lane, E Paige Stout, An-Shen Lin, et al.
Pageof 11